GIP modulates fat metabolism and food reward circuits
Semaglutide GLP-1 is a medication that has only recently been approved for medical weight loss and has proven to be very effective and a worthy competitor to what is available on the market
It helps lower blood glucose by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and reducing appetite
Potential Benefits for Endometriosis Reduced inflammation : Endometriosis is driven by chronic inflammation
Mechanism of Action: Semaglutide GLP-1 works by activating GLP-1 receptors in the brain and pancreas, resulting in several key benefits: Delayed Gastric Emptying: By slowing the rate at which food exits the stomach, semaglutide GLP-1 helps promote a feeling of fullness and reduces hunger, assisting in decreased calorie consumption
Nausea: Nausea is one of the most common gastrointestinal reactions in the early stages of GLP1 capsule treatment